KDM6A and colorectal carcinoma: Conversely, inhibition of the activity of demethylase KDM6A/KMD6B by GSK-J4 sensitized CRC to the effect of chemotherapeutic drugs by upregulating H3K27me3 levels in vivo and in vitro.